BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang P, Li Y, Tang W, Zhao J, Jing L, Mchugh KJ. Theranostic nanoparticles with disease-specific administration strategies. Nano Today 2022;42:101335. [DOI: 10.1016/j.nantod.2021.101335] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Zhang P, Tang W, McHugh KJ, Kershaw SV, Jiao M, Huang X, Kalytchuk S, Perkinson CF, Yue S, Qiao Y, Zhu L, Jing L, Gao M, Han B. Bright, Magnetic NIR-II Quantum Dot Probe for Sensitive Dual-Modality Imaging and Intensive Combination Therapy of Cancer. ACS Nano 2022. [PMID: 35442624 DOI: 10.1021/acsnano.2c01153] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Domingues C, Santos A, Alvarez-Lorenzo C, Concheiro A, Jarak I, Veiga F, Barbosa I, Dourado M, Figueiras A. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology. ACS Nano 2022. [PMID: 35729778 DOI: 10.1021/acsnano.2c00128] [Reference Citation Analysis]
3 Lin X, Li F, Gu Q, Wang X, Zheng Y, Li J, Guan J, Yao C, Liu X. Gold-seaurchin based immunomodulator enabling photothermal intervention and αCD16 transfection to boost NK cell adoptive immunotherapy. Acta Biomater 2022;146:406-20. [PMID: 35470078 DOI: 10.1016/j.actbio.2022.04.029] [Reference Citation Analysis]
4 Zhang P, Jing L. Nanoprobes for Visualization of Cancer Pathology in Vivo. Acta Chimica Sinica 2022;80:805. [DOI: 10.6023/a21120609] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Liang S, Liao G, Zhu W, Zhang L. Manganese-based hollow nanoplatforms for MR imaging-guided cancer therapies. Biomater Res 2022;26. [DOI: 10.1186/s40824-022-00275-5] [Reference Citation Analysis]
6 Zhong Y, Zeng X, Zeng Y, Yang L, Peng J, Zhao L, Chang Y. Nanomaterials-based imaging diagnosis and therapy of cardiovascular diseases. Nano Today 2022;45:101554. [DOI: 10.1016/j.nantod.2022.101554] [Reference Citation Analysis]
7 Zheng Z, Duan A, Dai R, Li Y, Chen X, Qin Y, Ren S, Li R, Cheng Z, Zhang R. A "Dual-Source, Dual-Activation" Strategy for an NIR-II Window Theranostic Nanosystem Enabling Optimal Photothermal-Ion Combination Therapy. Small 2022;:e2201179. [PMID: 35665998 DOI: 10.1002/smll.202201179] [Reference Citation Analysis]
8 Niu Y, Yang Y, Yang Z, Wang X, Zhang P, Lv L, Liu Y, Liu Y, Zhou Y. Aptamer-immobilized bone-targeting nanoparticles in situ reduce sclerostin for osteoporosis treatment. Nano Today 2022;45:101529. [DOI: 10.1016/j.nantod.2022.101529] [Reference Citation Analysis]
9 Yue S, Zhang X, Xu Y, Zhu L, Cheng J, Qiao Y, Dai S, Zhu J, Jiang N, Wu H, Zhang P, Hou Y. The influence of surface charge on the tumor-targeting behavior of Fe3O4 nanoparticles for MRI. J Mater Chem B 2022. [PMID: 34994759 DOI: 10.1039/d1tb02349g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li D, Wang T, Li L, Zhang L, Wang C, Dong X. Designed formation of Prussian Blue/CuS Janus nanostructure with enhanced NIR-I and NIR-II dual window response for tumor thermotherapy. Journal of Colloid and Interface Science 2022;613:671-80. [DOI: 10.1016/j.jcis.2022.01.074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]